Literature DB >> 26192320

Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown.

Anders Wittrup1, Angela Ai2, Xing Liu2, Peter Hamar3, Radiana Trifonova2, Klaus Charisse4, Muthiah Manoharan4, Tomas Kirchhausen5, Judy Lieberman6.   

Abstract

A central hurdle in developing small interfering RNAs (siRNAs) as therapeutics is the inefficiency of their delivery across the plasma and endosomal membranes to the cytosol, where they interact with the RNA interference machinery. With the aim of improving endosomal release, a poorly understood and inefficient process, we studied the uptake and cytosolic release of siRNAs, formulated in lipoplexes or lipid nanoparticles, by live-cell imaging and correlated it with knockdown of a target GFP reporter. siRNA release occurred invariably from maturing endosomes within ~5-15 min of endocytosis. Cytosolic galectins immediately recognized the damaged endosome and targeted it for autophagy. However, inhibiting autophagy did not enhance cytosolic siRNA release. Gene knockdown occurred within a few hours of release and required <2,000 copies of cytosolic siRNAs. The ability to detect cytosolic release of siRNAs and understand how it is regulated will facilitate the development of rational strategies for improving the cytosolic delivery of candidate drugs.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26192320      PMCID: PMC4663660          DOI: 10.1038/nbt.3298

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  29 in total

1.  Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.

Authors:  P L Felgner; T R Gadek; M Holm; R Roman; H W Chan; M Wenz; J P Northrop; G M Ringold; M Danielsen
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

2.  Internalization and trafficking of cell surface proteoglycans and proteoglycan-binding ligands.

Authors:  Christine K Payne; Sara A Jones; Chen Chen; Xiaowei Zhuang
Journal:  Traffic       Date:  2007-04       Impact factor: 6.215

Review 3.  Delivery materials for siRNA therapeutics.

Authors:  Rosemary Kanasty; Joseph Robert Dorkin; Arturo Vegas; Daniel Anderson
Journal:  Nat Mater       Date:  2013-11       Impact factor: 43.841

4.  Glycosphingolipids internalized via caveolar-related endocytosis rapidly merge with the clathrin pathway in early endosomes and form microdomains for recycling.

Authors:  Deepak K Sharma; Amit Choudhury; Raman Deep Singh; Christine L Wheatley; David L Marks; Richard E Pagano
Journal:  J Biol Chem       Date:  2002-12-12       Impact factor: 5.157

5.  Generation of destabilized green fluorescent protein as a transcription reporter.

Authors:  X Li; X Zhao; Y Fang; X Jiang; T Duong; C Fan; C C Huang; S R Kain
Journal:  J Biol Chem       Date:  1998-12-25       Impact factor: 5.157

6.  Autophagy induced by calcium phosphate precipitates targets damaged endosomes.

Authors:  Xi Chen; Bilon Khambu; Hao Zhang; Wentao Gao; Min Li; Xiaoyun Chen; Tamotsu Yoshimori; Xiao-Ming Yin
Journal:  J Biol Chem       Date:  2014-03-11       Impact factor: 5.157

7.  Lentivirus-delivered stable gene silencing by RNAi in primary cells.

Authors:  Sheila A Stewart; Derek M Dykxhoorn; Deborah Palliser; Hana Mizuno; Evan Y Yu; Dong Sung An; David M Sabatini; Irvin S Y Chen; William C Hahn; Phillip A Sharp; Robert A Weinberg; Carl D Novina
Journal:  RNA       Date:  2003-04       Impact factor: 4.942

8.  Rab proteins mediate Golgi transport of caveola-internalized glycosphingolipids and correct lipid trafficking in Niemann-Pick C cells.

Authors:  Amit Choudhury; Michel Dominguez; Vishwajeet Puri; Deepak K Sharma; Keishi Narita; Christine L Wheatley; David L Marks; Richard E Pagano
Journal:  J Clin Invest       Date:  2002-06       Impact factor: 14.808

9.  EEA1, an early endosome-associated protein. EEA1 is a conserved alpha-helical peripheral membrane protein flanked by cysteine "fingers" and contains a calmodulin-binding IQ motif.

Authors:  F T Mu; J M Callaghan; O Steele-Mortimer; H Stenmark; R G Parton; P L Campbell; J McCluskey; J P Yeo; E P Tock; B H Toh
Journal:  J Biol Chem       Date:  1995-06-02       Impact factor: 5.157

10.  Safety and efficacy of RNAi therapy for transthyretin amyloidosis.

Authors:  Teresa Coelho; David Adams; Ana Silva; Pierre Lozeron; Philip N Hawkins; Timothy Mant; Javier Perez; Joseph Chiesa; Steve Warrington; Elizabeth Tranter; Malathy Munisamy; Rick Falzone; Jamie Harrop; Jeffrey Cehelsky; Brian R Bettencourt; Mary Geissler; James S Butler; Alfica Sehgal; Rachel E Meyers; Qingmin Chen; Todd Borland; Renta M Hutabarat; Valerie A Clausen; Rene Alvarez; Kevin Fitzgerald; Christina Gamba-Vitalo; Saraswathy V Nochur; Akshay K Vaishnaw; Dinah W Y Sah; Jared A Gollob; Ole B Suhr
Journal:  N Engl J Med       Date:  2013-08-29       Impact factor: 91.245

View more
  143 in total

1.  Nanoparticles That Deliver RNA to Bone Marrow Identified by in Vivo Directed Evolution.

Authors:  Cory D Sago; Melissa P Lokugamage; Fatima Z Islam; Brandon R Krupczak; Manaka Sato; James E Dahlman
Journal:  J Am Chem Soc       Date:  2018-11-16       Impact factor: 15.419

Review 2.  Delivery of cancer therapeutics to extracellular and intracellular targets: Determinants, barriers, challenges and opportunities.

Authors:  Jessie L-S Au; Bertrand Z Yeung; Michael G Wientjes; Ze Lu; M Guillaume Wientjes
Journal:  Adv Drug Deliv Rev       Date:  2015-12-11       Impact factor: 15.470

3.  Gal8 Visualization of Endosome Disruption Predicts Carrier-Mediated Biologic Drug Intracellular Bioavailability.

Authors:  Kameron V Kilchrist; Somtochukwu C Dimobi; Meredith A Jackson; Brian C Evans; Thomas A Werfel; Eric A Dailing; Sean K Bedingfield; Isom B Kelly; Craig L Duvall
Journal:  ACS Nano       Date:  2019-01-18       Impact factor: 15.881

4.  The Niemann-Pick C1 Inhibitor NP3.47 Enhances Gene Silencing Potency of Lipid Nanoparticles Containing siRNA.

Authors:  Haitang Wang; Yuen Yi C Tam; Sam Chen; Josh Zaifman; Roy van der Meel; Marco A Ciufolini; Pieter R Cullis
Journal:  Mol Ther       Date:  2016-09-16       Impact factor: 11.454

5.  Modifying a Commonly Expressed Endocytic Receptor Retargets Nanoparticles in Vivo.

Authors:  Cory D Sago; Melissa P Lokugamage; Gwyneth N Lando; Naima Djeddar; Nirav N Shah; Chris Syed; Anton V Bryksin; James E Dahlman
Journal:  Nano Lett       Date:  2018-09-20       Impact factor: 11.189

Review 6.  Using Large Datasets to Understand Nanotechnology.

Authors:  Kalina Paunovska; David Loughrey; Cory D Sago; Robert Langer; James E Dahlman
Journal:  Adv Mater       Date:  2019-08-20       Impact factor: 30.849

Review 7.  Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems.

Authors:  S Guan; J Rosenecker
Journal:  Gene Ther       Date:  2017-01-17       Impact factor: 5.250

8.  Poly(amine-co-ester) nanoparticles for effective Nogo-B knockdown in the liver.

Authors:  Jiajia Cui; Alexandra S Piotrowski-Daspit; Junwei Zhang; Mingjie Shao; Laura G Bracaglia; Teruo Utsumi; Young-Eun Seo; Jenna DiRito; Eric Song; Christine Wu; Asuka Inada; Gregory T Tietjen; Jordan S Pober; Yasuko Iwakiri; W Mark Saltzman
Journal:  J Control Release       Date:  2019-05-01       Impact factor: 9.776

Review 9.  Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives.

Authors:  Wolfgang Poller; Stefanie Dimmeler; Stephane Heymans; Tanja Zeller; Jan Haas; Mahir Karakas; David-Manuel Leistner; Philipp Jakob; Shinichi Nakagawa; Stefan Blankenberg; Stefan Engelhardt; Thomas Thum; Christian Weber; Benjamin Meder; Roger Hajjar; Ulf Landmesser
Journal:  Eur Heart J       Date:  2018-08-01       Impact factor: 29.983

Review 10.  Knocking down disease: a progress report on siRNA therapeutics.

Authors:  Anders Wittrup; Judy Lieberman
Journal:  Nat Rev Genet       Date:  2015-09       Impact factor: 53.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.